Mercia Ventures and BGF led the Series A round to help the biotechnology firm commercialise its RNA sequencing technology.
"Genetic sequencing has come a long way since its inception in the 1970’s. The industry is now moving past short-read towards long-read sequencing, with long-read RNA sequencing being one of the most exciting new developments in biotechnology. We believe our solution could accelerate a new wave of biotechnology innovations. We are pleased to receive backing from some of the UK’s leading life science investors, which highlights its potential. The funding will help us to pursue our mission to reveal the unseen world of RNA and unlock exciting new applications."
Verisk and BGF have backed cyber risk management provider KYND in its latest funding round.
"KYND has developed an industry-leading platform that provides actionable insights on cyber risk posture. The business has demonstrated impressive growth and this new investment demonstrates our belief in the long-term potential of the company as it continues to scale."
The investment from BGF will support product development and sales growth.
"In the last eight years, we have built a highly successful, and profitable business through a balanced blend of strong industry experience and technical know-how."
The investment round was led by BGF, with additional backing from DSW Ventures.
"We have achieved a lot in a relatively short period but having the support of BGF will enable us to significantly accelerate all parts of our business and to firmly establish ourselves as the global leader in the next generation of market intelligence on the next generation of consumers. Having the backing of an experienced investor such as BGF, is an exciting validation of our commitment to reaching this goal."
The follow-on funding from BGF brings the company's total raised to £11.5m.
"This investment is a testament to the progress OSL has made since our initial collaboration with BGF. The infusion of £3.5 million is dedicated to continuing our trajectory of technological advancements and product development. Importantly, it enables us to invest in our most valuable asset—our people—creating job opportunities and reinforcing our commitment to excellence in business development."
